Jarui Pharmaceutical

Zhejiang Jarui Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in Central Nervous System (CNS) therapeutics, producing key products such as Gabapentin, Pregabalin, and various valproate salts. Operating out of GMP-certified facilities in Zhejiang province, Jarui Pharmaceutical serves both domestic and international markets, providing high-quality chemical intermediates and generic medications. Their business model integrates chemical synthesis with pharmaceutical production to ensure supply chain reliability for essential neurological treatments. The company is designated as a National High-tech Enterprise and maintains a focus on expanding its portfolio of CNS-related therapies.